Joakim Hertze

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment

Claudia Cicognola, Shorena Janelidze, Joakim Hertze et al. · Alzheimer s Research & Therapy · 2021 · 303 citations · Full text

Medicine, Neurology, Neuroscience +17

Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype

Shorena Janelidze, Joakim Hertze, Katarina Nägga et al. · Neurobiology of Aging · 2016 · 228 citations · Full text

Medicine, Neurology, Neuroscience +17

Cerebrospinal fluid neurogranin and <scp>YKL</scp> ‐40 as biomarkers of Alzheimer's disease

Shorena Janelidze, Joakim Hertze, Henrik Zetterberg et al. · Annals of Clinical and Translational Neurology · 2015 · 178 citations · Full text

Medicine, Neurology, Neuroscience +17

Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease

Mikko Hölttä, Oskar Hansson, Ulf Andréasson et al. · PLoS ONE · 2013 · 145 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

Joakim Hertze, Lennart Minthon, Henrik Zetterberg et al. · Journal of Alzheimer s Disease · 2010 · 132 citations · Full text

Medicine, Neurology, Neuroscience +17